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Background: Patients with heart failure (HF) frequently have instability of ventilatory control during exercise, termed exercise oscillatory ventilation 
(EOV). EOV is associated with decreased functional capacity and adverse prognosis, but is seldom recognized clinically nor during cardiopulmonary 
exercise testing. We sought to develop a method for detection and quantification of EOV which could be related to parameters of heart failure 
severity.
Methods: We defined normal variation of tidal volume, minute ventilation, oxygen consumption, carbon dioxide output, end-tidal carbon dioxide, 
and respiratory rate by analyzing breath-by-breath metabolic gas exchange in heart failure subjects (n=10) with no evidence of EOV on inspection of 
ventilatory patterns. We defined EOV as variation of parameters exceeding the 75th percentile compared to values obtained in controls. We applied 
the method to a group of New York Heart Association class III HF subjects (n=46) undergoing evaluation for cardiac resynchronization therapy. The 
severity of EOV was scored for each subject.
Results: A higher EOV score, indicating a greater magnitude of EOV, was positively associated with the ventilatory equivalent for carbon dioxide 
(R=0.47, p=0.001) and a shallow breathing pattern including greater physiologic dead space ventilation (R=0.45, p=0.003), and lower partial 
pressure of end-tidal carbon dioxide (R=0.40, p=0.008). The EOV score was also negatively associated with treadmill time (R=0.34, p=0.02), and 
positively associated with brain-type natriuretic peptide concentration (R=0.42, p=0.006).
Conclusions: EOV can be detected and quantified and correlates well with HF severity among NYHA Class III patients. Further work is needed to 
assess whether quantification of EOV can help inform HF prognosis and guide therapy in a wider range of patients.
